GlassScriptPhysician profile
Blair W Clementson
NPI 1326247909
$12,837.76
in general payments reported to CMS, 2019-2025
37 companies · $2,151 in 2025
The $2,151 reported for 2025 was more than what 77% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,541 · 2020: $1,292 · 2021: $1,457 · 2022: $2,002 · 2023: $1,922 · 2024: $2,472 · 2025: $2,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,437 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,437.02 |
| Education | $108.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,910.61 | 2019-2025 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $1,516.97 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Pfizer INC. | $1,241.43 | 2019-2025 | |
| Lilly USA, LLC | $1,019.02 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $783.27 | 2019-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $759.63 | 2019-2025 | |
| Amgen INC. | $745.04 | 2019-2025 | Otezla, Otezla |
| Ucb, INC. | $638.11 | 2019-2025 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $637.20 | 2019-2025 | Ilumya |
| E.R. Squibb & Sons, L.L.C. | $490.64 | 2022-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $460.54 | 2019-2025 | |
| Dermavant Sciences, INC. | $368.23 | 2023-2024 | Vtama |
| Leo Pharma INC. | $344.01 | 2019-2025 | Adbry, Anzupgo |
| Incyte Corporation | $338.19 | 2022-2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $244.33 | 2023-2025 | Zoryve |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $161.31 | 2019-2025 | Jublia, Cabtreo, Arazlo |
| Dermira, INC. | $115.32 | 2019-2021 | |
| Almirall LLC | $114.96 | 2019-2025 | Klisyri, Seysara |
| Vyne Pharmaceuticals INC. | $110.62 | 2020-2021 | |
| Celgene Corporation | $108.37 | 2019 | |
| Galderma Laboratories, L.P. | $103.91 | 2020-2025 | Nemluvio |
| Mayne Pharma Commercial LLC | $102.67 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.98 | 2022-2025 | Spevigo |
| Genentech USA, INC. | $87.95 | 2019-2023 | Erivedge |
| Inari Medical, INC. | $59.86 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Organon LLC | $50.03 | 2023-2025 | Hadlima, Vtama |
| Fresenius Kabi USA, LLC | $46.20 | 2023-2024 | Idacio |
| Merck Sharp & Dohme LLC | $31.16 | 2024 | Keytruda |
| Botanix Sb INC | $22.22 | 2025 | Sofdra |
| Journey Medical Corporation | $21.24 | 2022 | |
| Biofrontera INC. | $20.83 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Epi Health, LLC | $17.58 | 2022 | |
| Nabriva Therapeutics, Plc | $16.94 | 2021 | |
| Merz North America, INC. | $16.88 | 2025 | |
| Verrica Pharmaceuticals INC. | $16.24 | 2025 | Ycanth |
| Mylan Pharmaceuticals INC. | $14.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blair Clementson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.